Tobi, M.; Antaki, F.; Rambus, M.; Hellman, J.; Hatfield, J.; Fligiel, S.; McVicker, B.
Inflammatory Bowel Disease from the Perspective of Newer Innate Immune System Biomarkers. Gastrointest. Disord. 2025, 7, 22.
https://doi.org/10.3390/gidisord7010022
AMA Style
Tobi M, Antaki F, Rambus M, Hellman J, Hatfield J, Fligiel S, McVicker B.
Inflammatory Bowel Disease from the Perspective of Newer Innate Immune System Biomarkers. Gastrointestinal Disorders. 2025; 7(1):22.
https://doi.org/10.3390/gidisord7010022
Chicago/Turabian Style
Tobi, Martin, Fadi Antaki, MaryAnn Rambus, Jason Hellman, James Hatfield, Suzanne Fligiel, and Benita McVicker.
2025. "Inflammatory Bowel Disease from the Perspective of Newer Innate Immune System Biomarkers" Gastrointestinal Disorders 7, no. 1: 22.
https://doi.org/10.3390/gidisord7010022
APA Style
Tobi, M., Antaki, F., Rambus, M., Hellman, J., Hatfield, J., Fligiel, S., & McVicker, B.
(2025). Inflammatory Bowel Disease from the Perspective of Newer Innate Immune System Biomarkers. Gastrointestinal Disorders, 7(1), 22.
https://doi.org/10.3390/gidisord7010022